FUSN
Fusion Pharmaceuticals Inc
$21.4
Earnings Summary
Revenue | $33.64Mn |
Net Profits | $-28.18Mn |
Net Profit Margins | -83.78% |
Highlights
Fusion Pharmaceuticals Inc’s revenue jumped 23925.71% since last year same period to $33.64Mn in the Q4 2023. On a quarterly growth basis, Fusion Pharmaceuticals Inc has generated 1576.77% jump in its revenue since last 3-months.
Fusion Pharmaceuticals Inc’s net profit fell -14.47% since last year same period to $-28.18Mn in the Q4 2023. On a quarterly growth basis, Fusion Pharmaceuticals Inc has generated -63.34% fall in its net profits since last 3-months.
Fusion Pharmaceuticals Inc’s net profit margin jumped 99.52% since last year same period to -83.78% in the Q4 2023. On a quarterly growth basis, Fusion Pharmaceuticals Inc has generated 90.26% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Fusion Pharmaceuticals Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.37 |
EPS Estimate Current Year | -0.37 |
Highlights
Fusion Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at -0.37 - a -8.82% fall from last quarter’s estimates.
Fusion Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at -0.37.
Key Ratios
Key ratios of the Fusion Pharmaceuticals Inc post its Q4 2023 earnings
Earning Per Share (EPS) | -0.39 |
Highlights
Fusion Pharmaceuticals Inc’s earning per share (EPS) jumped 29.09% since last year same period to -0.39 in the Q4 2023. This indicates that the Fusion Pharmaceuticals Inc has generated 29.09% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-11-07 | -0.4 | -0.25 | 37.5% |
2024-03-20 | -0.34 | -0.39 | -14.71% |
2023-08-08 | -0.39 | -0.38 | 2.56% |
2023-05-11 | -0.32 | -0.45 | -40.63% |
₹0 US Stocks a/c Opening Fee